Veterinary Pathology
| Jeff L. Caswell | University of Guelph, Canada |
Veterinary Pathology is the premier international publication of basic and applied research involving domestic, laboratory, wildlife, marine and zoo animals, and poultry. Bridging the divide between natural and experimental diseases, the journal details the diagnostic investigations of natural and emerging diseases of animals; reports experimental studies enhancing understanding of the mechanisms of specific processes including cancer, infection, immunologic, metabolic and genetically mediated diseases; provides unique insights into animal models of human disease; and presents studies in identification and characterization of environmental (food, plant and chemical) and pharmaceutical hazards.
Written for veterinary pathologists, veterinary diagnostic laboratory staff, toxicologic pathologists, comparative pathologists, medical pathology researchers, environmental scientists, and others involved in veterinary diagnosis and animal research across all animal species, each issue features original articles, in-depth reviews, brief communications and unique case reports. Veterinary Pathology is at the forefront of important issues including emerging disease trends, biothreat, genetic modification of animals, food, chemical and drug safety, environmental monitoring, and diagnostic technologies.
The members of the distinguished editorial board are all internationally recognized in their specialty areas and have achieved awards and recognition attendant with their thought leader reputation.
Among the important topics covered are:
- Cancer Diagnosis and Prognosis
- Diseases Linked With the Environment
- Etiology and Pathogenesis
- Genetically modified animals
- Genomic, Proteomic and Imaging Technology
- Immunobiology
- Infectious Diseases
- Mechanisms
- Xenobiotic Injury
- Zoonotics
Special Focus Issues
Special Focus: Phenotyping Genetically Engineered Mice (GEMs) (January 2012)
The January 2012 issue focuses on te use of genetically engineered mice in biomedical research forms a cornerstone for advancing our understanding of disease. The phenotyping of mutant mice creates a foundation for defining the normal biology associated with the manipulated gene. However, extensive variation in background lesions and responses to myriad endemic infectious agents, even between in-bred laboratory mouse strains, complexes interpretations of histopathologic findings. The challenges in the evaluation of the genetic manipulation of mice, as an independent variable, should not be underestimated. This special focus issue highlights some of these confounding factors, as well as includes GEM phenotyping information not previously gathered together and/or presented in journal format. This issue will emphasize some of the complexities in evaluating gene modifications in mice and will serve as a reference and a resource for pathologists and researchers alike, in their search to better understand genetic function and disease.
Special Focus: Diagnosis and Prognosis of Companion Animal Neoplastic Diseases (January 2011)
The January 2011 issue focuses on veterinary oncology. A lead manuscript, “Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology,” represents the consensus of an international group of veterinary pathologists, oncologists, and epidemiologists, highlighting the importance of close collaboration among veterinary pathologists and oncologists to advance our abilities to diagnose, prognosticate, and successfully treat animal cancer. A series of manuscripts focus on the current state of prognostication and diagnosis of canine neoplastic diseases, including melanomas, mast cell tumors, mammary carcinomas, soft tissue sarcomas, myeloid leukemias, and lymphomas. Additional consensus manuscripts address the trimming, margin evaluation, and reporting of surgical biopsy samples, the classification of canine malignant lymphomas, and the grading of mast cell tumors. Additional review papers provide detailed insight into current techniques for the diagnosis of neoplastic disease, such as flow cytometry, and highlight the importance of integrating recently gained molecular understanding, such as loss of heterozygocity, into the evaluation of neoplastic diseases. With the emerging use of dogs and cats as models for human neoplastic diseases, well established and uniformly applied criteria to classify companion animal neoplastic disease will form a cornerstone in extrapolation of learnings across species.
Special Focus: Research Challenges and Animal Models in Biological Defense (September 2010)
The September 2010 issue focuses on research challenges and animal models in biological defense. Medical countermeasures against deadly biological select agents like anthrax, Ebola virus, smallpox and highly pathogenic influenza viruses are greatly needed to combat infections that may arise naturally or through acts of bioterrorism or biowarfare. Animal diseases involving such agents are important in their own right or as models of human infections necessary to develop vaccines, therapeutics or other countermeasures. The articles in this issue illustrate the many scientific, regulatory, safety and security challenges that research with biological select agents and toxins must overcome. They also provide a current knowledge base for animal models of several major select agents. A profound expansion of biomedical defense efforts in the United States and other countries in the last decade has provided numerous opportunities at established and recently minted facilities around the world. This issue seeks to engender, among pathologists and biologists of many disciplines, a better understanding of existing biological threats in order to show the way forward and promote the development of the medical countermeasures.
Special Focus: Emerging Diseases and Global Surveillance (January 2010)
The January 2010 issue focuses on emerging and expanding diseases that have caused significant disruptions in recent years. Bird ‘flu, foot-and-mouth disease, bluetongue, and melamine - all emerged in new places or new hosts to cause economic or public health panics. The articles chronicle the underlying reasons and highlight the global disparities in recognition and response capacities, which will ensure continuing emergence. Opportunities abound for recognizing emerging diseases, creating sound public policies, and promoting programs that protect agricultural and public health. This issue encourages animal health communities, in cooperation with local, state, federal, and international agencies, to develop proactive cooperative programs designed to detect and limit these outbreaks.
This journal is a member of the Committee on Publication Ethics (COPE).
Veterinary Pathology, an international journal of natural and experimental disease, publishes manuscripts, reviews, brief communicatons, case reports, editorials, letters, and advertisements for employment opportunities and new products.
| Jeff Caswell | University of Guelph, Canada |
| Andrea Gröne | Utrecht University, Netherlands |
| Jyoji Yamate | Osaka Prefecture University, Japan |
| Paola Roccabianca | University of Milan, Italy |
| Joshua Webster | Genentech, USA |
| Patricia Pesavento | University of California - Davis, USA |
| Jens P. Teifke | Friedrich-Loeffler-Institut, Germany |
| Makoto Shibutani | Tokyo University of Agriculture and Technology, Japan |
| Leslie Sharkey | Tufts University, USA |
| Howard B. Gelberg | Oregon State University, USA |
| Dalen Agnew | Michigan State University, USA |
| Jerrold M. Ward | Global Vet Pathology, Montgomery Village, MD, USA |
| David Meyerholz | The University of Iowa, USA |
| Eric Blomme | AbbVie Laboratories, USA |
| Piper Treuting | University of Washington, USA |
| Hannah Bender | Taronga Conservation Society, Australia |
| Silvia Ferro | University of Padova, Italy |
| Deborah M. Gillette |
| Linden Craig | University of Tennessee, USA |
| Richard Fox | Finn Pathologists, UK |
| Ingeborg Langohr | Louisiana State University, USA |
| Diane Gunson | Novartis Pharmaceuticals, Switzerland |
| Leah Schutt | Genentech, USA |
| Aníbal G. Armién | University of Minnesota, USA |
| Wolfgang Baumgärtner | University of Veterinary Medicine Hannover, Germany |
| Amanda Beck | Albert Einstein College of Medicine, USA |
| Ingrid L. Bergin | University of Michigan-Ann Arbor, USA |
| Rachel E. Cianciolo | The Ohio State University, USA |
| Nathaniel Collins | Celgene Corporation, USA |
| Timothy K. Cooper | Penn State College of Medicine, USA |
| Amy Durham | University of Pennsylvania, USA |
| Stina Ekman | Swedish University of Agricultural Sciences, Sweden |
| Joy Gary | Centers for Disease Control and Prevention, USA |
| Katherine Gibson-Corley | University of Iowa, USA |
| Kathleen Kelly | Cornell University, USA |
| Takashi Kimura | Hokkaido University, Japan |
| Anja Kipar | University of Zurich, Switzerland |
| Thijs Kuiken | Erasmus Medical Center |
| Raoul Kuiper | Karolinska Institute, Sweden |
| Elise LaDouceur | Joint Pathology Center, USA |
| Keith E. Linder | North Carolina State University, USA |
| Christiane Löhr | Oregon State University, USA |
| Eric Lombardini | US Army Veterinary Corps, USA |
| Elizabeth Mauldin | University of Pennsylvania, USA |
| Takehito Morita | Tottori University, Japan |
| Aisuke Nii | Seikagaku Corporation, Japan |
| Francesco C. Origgi | University of Bern, Switzerland |
| Alessandra Piersigilli | Weill Cornell Medicine, USA |
| Brian Porter | Texas A&M University, USA |
| Horst Posthaus | University of Bern, Switzerland |
| Simon Priestnall | The Royal Veterinary College, UK |
| Enrico Radaelli | University of Pennsylvania, USA |
| Jose Ramos-Vara | Purdue University, USA |
| Lorenzo Ressel | University of Liverpool, UK |
| Hiroki Sakai | Gifu University, Japan |
| Kelly Santangelo | Colorado State University, USA |
| Chandra Saravanan | Novartis Pharmaceuticals, Switzerland |
| Giuseppe Sarli | University of Bologna, Italy |
| Robert Sills | National Institute of Environmental Health Sciences, USA |
| Leonardo Susta | University of Guelph, Canada |
| Leandro Teixeira | University of Wisconsin, USA |
| Kazuyuki Uchida | The University of Tokyo, Japan |
| Enric Vidal Barba | IRTA-CReSA, Spain |
| Peter Vogel | St. Jude Children's Research Hospital, USA |
| Kurt Williams | Michigan State University, USA |
| Valentina Zappulli | University of Padua, Italy |
IMPORTANT CHANGES IN MANUSCRIPT SUBMISSION, REVIEW, AND PUBLICATION!
For complete manuscript submission guidelines, please click HERE for a downloadable PDF.
SUBMISSION OF MANUSCRIPTS
SAGEtrack is the online manuscript tracking system provided by SAGE Publications. Using this system, all aspects of the review process are carried out online. To submit an article online, please go to the journal’s SAGEtrack website at http://mc.manuscriptcentral.com/vetpath.
Average time from submission to first decision: 27 days.
If you do not have access to the necessary resources for online submission, please send one copy of your manuscript, a cover letter giving the corresponding author’s address, telephone and fax numbers, and e-mail address; a diskette or CD containing the text of your article in Word format; and one copy of your tables and figures to the Editorial Office of Veterinary Pathology at the following address:
Jill Findlay
Managing Editor, Veterinary Pathology
Phone/Fax: 919-793-4777
Email: vetpathjournal@outlook.com